Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world-Reference-Cited by-同舟云学术

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world

Published:2021-07-10 Issue:4 Volume:37 Page:990-1006
ISSN:1880-4276
Container-title:Journal of Arrhythmia
language:en
Short-container-title:J Arrhythmia

Author:

Kozieł Monika¹²^ORCID,Teutsch Christine³,Bayer Valentina⁴,Lu Shihai⁴,Gurusamy Venkatesh K.⁵,Halperin Jonathan L.⁶,Rothman Kenneth J.⁷,Diener Hans‐Christoph⁸,Ma Chang‐Sheng⁹¹⁰,Huisman Menno V.¹¹,Lip Gregory Y. H.¹²¹²^ORCID,

Affiliation:

1. Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart and Chest Hospital Liverpool UK

2. Department of Cardiology and Angiology Silesian Centre for Heart Diseases Zabrze Poland

3. Department of Clinical Development and Medical Affairs Therapeutic Area Cardiometabolism Boehringer Ingelheim International GmbH Ingelheim Germany

4. Biostatistics and Data Sciences Department Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield CT USA

5. Global Epidemiology Boehringer Ingelheim International GmbH Ingelheim Germany

6. Icahn School of Medicine at Mount Sinai New York City NY USA

7. RTI Health Solutions Research Triangle Park NC USA

8. Institute for Medical Informatics, Biometry and Epidemiology Essen Germany

9. University of Duisburg‐Essen Essen Germany

10. Cardiology Department Atrial Fibrillation Center Beijing Anzhen HospitalCapital Medical University Beijing China

11. Department of Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands

12. Aalborg Thrombosis Research Unit Department of Clinical Medicine Aalborg University Aalborg Denmark

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/joa3.12588

Reference31 articles.

1. Antithrombotic Therapy for Atrial Fibrillation

2. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

3. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

4. A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

5. Disengaging from statistical significance

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project;Clinical Research in Cardiology;2024-08-08

2. Recommendations for Implementing the INTERACT3 Care Bundle for Intracerebral Hemorrhage in Latin America: Results of a Delphi Method;Cerebrovascular Diseases;2024-07-04

3. Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies;Thrombosis Research;2024-06

4. Recommendations for implementing the INTERACT3 care bundle for intracerebral hemorrhage in Latin America: a Delphi Study;2024-03-08

5. Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke;Open Heart;2023-12